| A phase 2 trial of the GSK‐3 inhibitor tideglusib in progressive supranuclear palsy E Tolosa, I Litvan, GU Höglinger, D Burn, A Lees, MV Andrés, ... Movement Disorders 29 (4), 470-478, 2014 | 337 | 2014 |
| Tideglusib reduces progression of brain atrophy in progressive supranuclear palsy in a randomized trial GU Höglinger, HJ Huppertz, S Wagenpfeil, MV Andrés, V Belloch, T León, ... Movement Disorders 29 (4), 479-487, 2014 | 160 | 2014 |
| Absence of functional TolC protein causes increased stress response gene expression in Sinorhizobium meliloti MR Santos, AM Cosme, JD Becker, JMC Medeiros, MF Mata, LM Moreira BMC microbiology 10, 1-18, 2010 | 44 | 2010 |
| Intracoronary delivery of human mesenchymal/stromal stem cells: insights from coronary microcirculation invasive assessment in a swine model A Fiarresga, MF Mata, S Cavaco-Goncalves, M Selas, IN Simoes, ... PLoS One 10 (10), e0139870, 2015 | 26 | 2015 |
| Influence of the mesenchymal stromal cell source on the hematopoietic supportive capacity of umbilical cord blood-derived CD34+-enriched cells S Bucar, ADM Branco, MF Mata, JC Milhano, Í Caramalho, JMS Cabral, ... Stem Cell Research & Therapy 12, 1-16, 2021 | 16 | 2021 |
| A modified CD34+ hematopoietic stem and progenitor cell isolation strategy from cryopreserved human umbilical cord blood MF Mata, D Hernandez, E Rologi, D Grandolfo, E Hassan, P Hua, ... Transfusion 59 (12), 3560-3569, 2019 | 13 | 2019 |
| Severity dependent distribution of impairments in PSP and CBS: Interactive visualizations C Brittain, A McCarthy, MC Irizarry, D McDermott, K Biglan, GU Höglinger, ... Parkinsonism & related disorders 60, 138-145, 2019 | 11 | 2019 |
| Enhancement of mouse hematopoietic stem/progenitor cell function via transient gene delivery using integration-deficient lentiviral vectors ME Alonso-Ferrero, NP van Til, K Bartolovic, MF Mata, G Wagemaker, ... Experimental Hematology 57, 21-29, 2018 | 7 | 2018 |
| Scaling up the ex vivo expansion of human circulating CD34+progenitor cells with upregulation of angiogenic and anti-inflammatory potential. MAC Márcia F. Mata, João Pedro Lopes, Masakazu Ishikawa, Mohamad A. Alaiti ... Cytotherapy, 2015 | 7 | 2015 |
| Magnetic Resonance Imaging Measures to Track Atrophy Progression in Progressive Supranuclear Palsy in Clinical Trials A Quattrone, N Franzmeier, HJ Huppertz, M Klietz, SN Roemer, ... Movement Disorders, 2024 | 1 | 2024 |
| ALLOGENEIC IPSC-DERIVED NK THERAPEUTIC PRODUCT: PHENOTYPIC ANALYSIS AND FUNCTIONAL CHARACTERIZATION M Houppermans, L Lam, MF Mata, S Luharia, A Habich-Crayton, ... Cytotherapy 26 (6), e27, 2024 | | 2024 |
| SIMPLIFYING IPSC TO NK MANUFACTURING USING AUTOMATED BIOPROCESSING AND DEEPER PROCESS AND PRODUCT CHARACTERISATION. MF Mata, J Guenat, M Henry, VD Fernandez, M Tregidgo, M Jayawardena, ... Cytotherapy 26 (6), S169, 2024 | | 2024 |
| Towards a scalable, closed and automated platform for the production of cost-efficient allogeneic cell therapies: showcase of an exemplar iNK process MF Mata, J Guenat, J Hasan, V Del Solar Fernandez, M Henry, A Nair, ... | | 2024 |
| Development of an end-to-end platform for the controlled, closed, scalable and cost-effective manufacture of allogeneic therapies derived from pluripotent stem cells in … N Agabalyan, MF Mata, J Guenat, IA Valero, H Galali, E Chikunova, ... Cytotherapy 22 (5), S40, 2020 | | 2020 |
| Development of cost efficient platforms for the industrial manufacture of pluripotent stem cell-derived products for cell therapy R Macown, D Popova, J Hasan, E Rologi, M Bell, S Senderovich, ... HUMAN GENE THERAPY 28 (12), A88-A88, 2017 | | 2017 |
| 720. Transient Expression of Genes From Integrative Deficient Lentiviral Vectors Improves Blood Progenitor Cell Expansion, Survival and Engraftment ME Alonso-Ferrero, K Bartolovic, C Kinnon, M Mata, SN Waddington, ... Molecular Therapy 22, 1, 2014 | | 2014 |
| Transient Expression of Genes From Integrative Deficient Lentiviral Vectors Improves Blood Progenitor Cell Expansion, Survival and Engraftment ME Alonso-Ferrero, K Bartolovic, C Kinnon, M Mata, SN Waddington, ... MOLECULAR THERAPY 22, S278-S278, 2014 | | 2014 |
| Transient manipulation of haematopoietic stem cells with integrative deficient lentiviral vectors for improved cell expansion, survival and engraftment ME Alonso-Ferrero, K Bartolovic, C Kinnon, M Mata, MD Milsom, ... HUMAN GENE THERAPY 24 (12), A35-A35, 2013 | | 2013 |
| Manipulation of haematopoietic stem cell biology using transient gene expression from integration-deficient lentiviral vectors M Alonso-Ferrero, N van Til, K Bartolovic, C Kinnon, M Mata, M Milsom, ... HUMAN GENE THERAPY 24 (5), A33-A33, 2013 | | 2013 |
| British Society for Gene and Cell Therapy (BSGCT) Conference Abstracts Royal Holloway University of London 17–19 April, 2013 C Denning, GM Ellison, K Mitrophanous, L Seymour, JCI Belmonte, ... | | 2013 |
